TheraNews Logo

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine ...

postregister|1/15/2026|depression
Share this article:
Email

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine ...

ONLY AVAILABLE IN PAID PLANS.


Originally reported by postregister. Read more

Share this article:
Email

Related Articles

More stories about depression